65 results about "Bacopa monnieri" patented technology

The present invention relates to a nutritional supplement composition, comprising a therapeutically effective amounts of Vitamin C, Vitamin D3, Thiamin, Riboflavin, Niacin, Vitamin B6, Folic acid, Vitamin B12, Pantothenic acid, Calcium, Magnesium, Zinc, Chromium, Sugar, Protein, Acetyl-L-Carnitine, Dimethylaminoethanol complex, Phosphatidylserine complex, L-Glutamine, N-Acetyl-L-Tyrosine, L-Phenylalanine, Taurine, Methionine, Valine, Isoleucine, 5 Hydroxytryptophan, L-Taurine, N-Acetyl-Tyrosine, N-Acetyl-L-Cysteine, Alpha Lipoic Acid, Alpha Glycerylphosphoricholine complex, Bacopa Monnieri extract, Gingko Biloba extract, Passion flower, Lemon Balm, Gotu Kola, Ashwagandha, Choline Bitartrate complex, Panax Ginseng extract, Turmeric, Organic freeze dried fruit juice blends (concord grape, red raspberry, pineapple, cranberry, acai, pomegranate, acerola cherry, bilberry, lingonberry, black currant, aronia, sour cherry, black raspberry), Organic freeze dried greens blends (barley grass, broccoli, beet, carrot, alfalfa, oat), and Protein digestive enzyme blends (Protease 4.5, peptidase, bromelain, protease 6.0, protease 3.0, L planatrum, B bifidum) in a mixture to provide optimal cognitive function.

The invention provides water moisturizing cream. The water moisturizing cream is prepared from the following components: cyclopentasiloxane, polydimethylsiloxane, cetyl PEG/PPG-10/1 polydimethylsiloxane, cyclopentasiloxane/polydimethylsiloxane cross-linked polymer, essence, glycerol, butanediol, propylene glycol, panthenol, glycine betaine, sodium chloride, crylic acid (ester)/beheneth-25 methacrylate copolymer, sodium hydroxide, sodium hyaluronate, daisy flower extract, kappaphycus alvarezii extract, chlorella/white lupine protein fermented product, glycyrrhiza glabra root extract, extract of all-grass of Bacopa monnieri ( L .) Wettst., bio-saccharide gum, phenoxyethanol/ethylhexylglycerin and deionized water. The water moisturizing cream provided by the invention is good in stability, good in closing property, and durable in moisture retention, and has soft and smooth applying feel.

Two very important factors in human life—which play vital roles in promoting well being—includes returning the body to homeostasis and giving boost to body called lifeforce to get overall health free from diseases, i.e., its optimal balanced functioning ability. When the body is at homeostasis, there is no place for disease. It is only when the body is out of balance (something is deficient, in excess or stagnating) that pain, illness or disease can occur. The application described is based on returning the body to homeostasis (removing the problem and balancing the body) by providing lifeforce and not on dealing with the symptom (e.g., pain, vitamin deficiency). Imbalance results in various diseases and adverse health conditions (starting from aging to diabetes and cancers). This wonderful composition will interact with the body in a way that allows it to boost lifeforce and reach homeostasis no matter which direction it was. In this combination, in the form of liquid, all the 14 ingredients (Lepidium meyenii (Maca), Croton planstigma (Dragon's blood) tree sap, Uncaria tomentosa (Cat's Claw), Morinda citrifolia (Noni fruit) 4:1 PE, Lutein, Lycopene 5%, Flaxseed Oil (Omega-3-Fatty Acids), Vinpocetine, Phosphatidyl Serine 50%, Korean Ginseng 80%, Bacopa monnieri (Bacopin), CDP Choline (Cognizing), Guaranine (Guarana Seed PE 12%), Yerba Mate Ext. 8%) work as mixture for returning the body to homeostasis and give it lifeforce.

The invention discloses a traditional Chinese medicine composition for treating swine mange. The traditional Chinese medicine comprises is prepared from the following raw medicines in parts by weight: 700 to 1,200 parts of bacopa monnieri, 500 to 1,000 parts of cortex dictamni, 300 to 800 parts of radix sophorae flavescentis, 300 to 800 parts of fructus cnidii, and 100 to 500 parts of sulphur. In addition, the invention also discloses a preparation method of the traditional Chinese medicine. The traditional Chinese medicine can be used both external and internal and can treat from external and internal; when in internal use, the traditional Chinese medicine composition has the effects of clearing heat and cooling blood, removing toxicity for detumescence, strengthening Yang and relaxing bowels, cleaning blood and promoting metabolism, and cuts off a nutrient source of sarcoptic mites so that the foundation for the sarcoptic mite to attach to a swine body is removed; when in external use, the traditional Chinese medicine composition has the effects of disinfecting and disinsectizing, eliminating dampness and relieving itching, promoting tissue regeneration and repairing epidermal tissue, and can control the disease quickly; by adopting such combination, the best of each raw medicine is brought out, good effect of treating both symptoms and root causes is realized, and thus the swine mange and scab can be cured completely.

A concentration and mental performance amplifying formulation comprising rhodiola rosea and geranium oil, together with at least one of vinpocetine, phosphatidylcholine, caffeine and Salix alba (White Willow Bark). In another aspect, there is disclosed a concentration and mental performance amplifying formulation comprising: rhodiola rosea, geranium oil, and at least one of anhydrous caffeine and nicotine. In yet another aspect, there is disclosed a concentration and mental performance amplifying formulation as last described which further comprises: Vinpocetine, or Vincamine together with Huperzine-A, or Vinca minor (Periwinkle) together with Huperzine-A; PhosphatidylCholine or Bacopa monnieri (Brahmi) or Mucuna pruriens; Nicotinamide Adenine Dinucleotide Hydrate; and Salix alba (White Willow Bark). Also described is a method of amplifying concentration and mental performance in a human subject by administering such formulations to such a subject.

The invention provides an application of total saponins of bacopa monnieri (L.) wettst. in preparation of medicaments for resisting cerebral ischemia. The total saponins of the bacopa monnieri (L.) wettst. mainly comprise the following dammarane type triterpenoid saponin compounds: bacopaside I, bacoside A3, bacopaside II, bacopasaponin cisomer and bacopasaponin C. The invention further provides an application of the bacopaside I in preparation of a medicament for resisting cerebral ischemia. The experimental study shows that the total saponins of the bacopa monnieri (L.) wettst. and the bacopaside I have the effects of improving the behavioral symptoms caused by cerebral ischemia reperfusion injury, reducing the cerebral infarct volume and reducing the cerebral edema caused by cerebral ischemia of a rat. Therefore, the total saponins of the bacopa monnieri (L.) wettst. can be used for preparing the medicaments for preventing and treating cerebral ischemia. The medicaments for preventing and treating the cerebral ischemia are prepared from the total saponins of the bacopa monnieri (L.) wettst. or bacopaside I as the active component and medicinal accessories by adopting a conventional method. The invention further expands the function of the bacopaside I and the total saponins of the bacopa monnieri (L.) wettst. and provides the novel medicaments for preventing and treating the cerebral ischemia. The bacopaside I and the total saponins of the bacopa monnieri (L.) wettst. have high clinical application values.

A composition for the topical application on a mammalian skin comprises one or more Brassica plant extracts selected from the group consisting of: Brassica juncea extract, Brassica oleracea italica extract, Brassica oleracea capitata extract, Brassica oleracea botrytis extract, and Brassica oleracea acephala extract. The composition further comprises one or more selected from the group consisting of: Curcuma longa extract, curcuminoids, tetrahydrocurcuminoids, metabolites of curcuminoids or tetrahydrocurcuminoids, and derivatives of curcuminoids or tetrahydrocurcuminoids. The composition further comprises one or more selected from the group consisting of: Camellia oleifera extract, Camellia sinensis extract, green tea extract and white tea extract; Wasabia japonica extract; Bacopa monnieri extract; Silybum marianum extract; and one or both of Piper nigrum extract or tetrahydropiperine.

This document provides dietary supplement compositions. For example, dietary supplement compositions having an acetylcholinesterase inhibitor (e.g., huperzine A), a Bacopa monnieri extract, acetyl-L-carnitine or acetyl CoA, and a curcuminoid (e.g., curcumin) are provided.

The invention discloses a mild skin brightening body lotion, which comprises bacopa monniera extract, eugenol, hibiscus flower extract, jojoba seed oil, squalane, propylene glycol, glycerin, glyceryl stearate, stearyl alcohol Polyether‑21, hydrogenated olive oil and other ingredients. The mild plant active ingredients are non-irritating to the skin, and endow the product with significant anti-oxidation and antibacterial effects; the body milk of the present invention can replenish moisture to the skin, balance the skin tone, and brighten the skin color, making the skin fairer and more elastic; It can inhibit inflammatory factors and has a certain healing effect on inflamed skin.

An extract of pseudo-portulaca, which contains the pseudo-portulaca saponin (20-80 Wt %), is disclosed. A composite medicine containing said extract, its preparing process and its application are disclosed.

A herbal preparation for management of cardiovascular and neurologic disorders comprising at least two of the following constituents, and preferably all three: 1. Dioscorea bulbifera, 2. Hippophae rhamnoides, 2. Bacopa monnieri and present in the range of: 1. Dioscorea bulbifera 200-500 mg, 2. Hippophae rhamnoides 150-400 mg, 3. Bacopa monnieri 100-500 mg for every 1000 mg of said preparation.

The invention provides a separation and purification method of a bacopa monnieri total saponin extract. The method comprises the following steps: adding alcohol (80%) into bacopa monnieri, carrying out extraction, merging extracts, concentrating the merged extract; adding alcohol (95%) into the concentrate to prepare a loading solution with a medicinal material content of 0.311 g/mL; using HP-20 macroporous resin to carry out wet process packing and loading until all loading solution is loaded, collecting the eluent, and carrying out reduced pressure distillation to obtain a bacopa monnieri total saponin extract. The purity of total saponins is 51.19 to 55.67%, and the total saponin transfer rate is 76.96 to 78.29%. The invention provides an application of the bacopa monnieri total saponinextract in the preparation of nervous system drugs including drugs for treating depression and dementia. The toxic and side effect of chemical drugs is overcome, and the bacopa monnieri total saponinextract has a wide application prospect in clinic. The separation and purification method adopts macroporous resin to separate and purify the bacopa monnieri total saponin extract; the operation is simple, and the method is suitable for industrial production and has a great application value.

The invention provides a skincare composition which comprises simmondsia chinensis seed oil, nicotinamide, an aloe vera extract, a bacopa monnieri extract and a pomegranate seed extract. The invention further provides eye cream which comprises the skincare composition mentioned in the technical scheme. Compared with the prior art, the skincare composition provided by the invention contains the simmondsia chinensis seed oil, the nicotinamide, the aloe vera extract, the bacopa monnieri extract and the pomegranate seed extract, and the substances are matched with one another for a synergistic effect, so that the obtained skincare composition is good in skin feeling, quick in absorption, fresh and not greasy. When the skincare composition provided by the invention is used for preparing the eye cream, the obtained eye cream can have good anti-wrinkle and anti-aging effects at the same time, and the comfortable feeling during skin protection is increased.

The invention belongs to the field of hair dyes, and provides a paste-like natural plant hair dye, which mainly consists of the following components: indigo, henna, bacopa monniera, madder, acacia, emblica, catechu, coffee tree, Eclipta, osmotic agent, absorbent, thickener, add deionized water to make a paste. The hair dye uses pure natural non-toxic plants as the main raw material of the hair dye, is rich in natural nutrients, has the advantages of non-irritation and non-allergic, and has the effect of nourishing and protecting hair after long-term use.

The present invention features a composition including (i) an oxygen labile active agent, and (ii) a plant extract selected from Chrysanthellum extract, Neem extract, Lanatellys extract, Bacopa Monnieri extract, and Olive leaf extract.

The invention discloses a preparation for cancer patients to take during radiotherapy and chemotherapy. The preparation comprises the following raw materials in weight part: 7-11 parts of curcuma aromatica, 4-8 parts of goldfussia psilostachys, 9-12 parts of Bacopa monnieri Wettst, 8-11 parts of bamboo iris, 5-8 parts of lantern plant calyx, 4.5-7.5 parts of Impatiens aquatilis Hook. f., 2-4 parts of viburnum sargenti, 6-10 parts of codonopsis pilosula, 4-7 parts of the roots of Rubus coreanus Miq., 3-6 parts of Halenia corni, 2-5 parts of Radermachera sinica, 5.5-8.5 parts of acacia rattan, 2.6-5.2 parts of tubeflower viburnum herb, and 1-4 parts of berchemia lineate. The preparation can significantly reduce the toxic and side effects of radiotherapy and chemotherapy, improve the treatment rate, and prolong the survival time of patients.

The invention discloses an insecticide composition containing bacopaside II, which includes the bacopaside II and pinocembrin according to the weight part ratio of 1:1-30:1. In the invention, the bacopaside II and the pinocembrin are compounded at certain ratio, so that the insecticide composition has excellent synergistic effect in prevention and treatment on bradysia odoriphaga; and especially, when the weight part ratio of the bacopaside II to the pinocembrin is 19-20:1, the synergistic effect is more significant.

The invention discloses external traditional Chinese medicine for treating external hemorrhoid. The external traditional Chinese medicine is prepared from the following raw materials in parts by weight: 5-7 parts of Chinese taxillus twig, 3-5 parts of dahurian angelica root, 5-7 parts of sinkiang arnebia root, 2-4 parts of lightyellow sophora root, 6-8 parts of Chinese arborvitae twig, 2-4 parts of dragon blood, 1-3 parts of adiantum capillus-veneris, 3-5 parts of Chinese thorowax root, 6-8 parts of garden burnet leaf, 4-5 parts of skunk bugbane, 3-5 parts of roasted liquoric root, 2-4 parts of dandelion, 5-7 parts of sweet potato leaves, 5-10 parts of parslane herb, 10-15 parts of chrysanthemum, 10-15 parts of white radish leaf, 3-5 parts of bitter orange, 2-4 parts of philippine violet herb, 1-3 parts of twotooth achyranthes, 3-5 parts of agrimony, 3-5 parts of bacopa monnieri, 2-4 parts of herb of ceylon leucas and 1-2 parts of longestapex beautyberry leaf. The traditional Chinese medicine is prepared in a scientific and complementary manner, and has the effects of clearing heat, promoting diuresis, activating blood circulation to dissipate blood stasis, relieving swelling and pain, healing sore and relieving pain. The external traditional Chinese medicine is low in price, is definite in curative effect and safe, is free from toxic and side effects, and is 100 percent in effective rate. As proven by years of clinical application, the external traditional Chinese medicine has a remarkable curative effect, and is very easy for patients to accept.